Cargando…

Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics

The field of induced proximity therapeutics is in its ascendancy but is limited by a lack of scalable tools to systematically explore effector-target protein pairs in an unbiased manner. Here, we combined Scalable POoled Targeting with a LIgandable Tag at Endogenous Sites (SPOTLITES) for the high-th...

Descripción completa

Detalles Bibliográficos
Autores principales: Serebrenik, Yevgeniy V., Mani, Deepak, Maujean, Timothé, Burslem, George M., Shalem, Ophir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543026/
https://www.ncbi.nlm.nih.gov/pubmed/37790450
http://dx.doi.org/10.21203/rs.3.rs-3161717/v1
_version_ 1785114210659729408
author Serebrenik, Yevgeniy V.
Mani, Deepak
Maujean, Timothé
Burslem, George M.
Shalem, Ophir
author_facet Serebrenik, Yevgeniy V.
Mani, Deepak
Maujean, Timothé
Burslem, George M.
Shalem, Ophir
author_sort Serebrenik, Yevgeniy V.
collection PubMed
description The field of induced proximity therapeutics is in its ascendancy but is limited by a lack of scalable tools to systematically explore effector-target protein pairs in an unbiased manner. Here, we combined Scalable POoled Targeting with a LIgandable Tag at Endogenous Sites (SPOTLITES) for the high-throughput tagging of endogenous proteins, with generic small molecule-based protein recruitment to screen for novel proximity-based effectors. We apply this methodology in two orthogonal screens for targeted protein degradation: the first using fluorescence to monitor target protein levels directly, and the second using a cellular growth phenotype that depends on the degradation of an essential protein. Our screens revealed a multitude of potential new effector proteins for degradation and converged on members of the CTLH complex which we demonstrate potently induce degradation. Altogether, we introduce a platform for pooled induction of endogenous protein-protein interactions that can be used to expand our toolset of effector proteins for targeted protein degradation and other forms of induced proximity.
format Online
Article
Text
id pubmed-10543026
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Journal Experts
record_format MEDLINE/PubMed
spelling pubmed-105430262023-10-03 Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics Serebrenik, Yevgeniy V. Mani, Deepak Maujean, Timothé Burslem, George M. Shalem, Ophir Res Sq Article The field of induced proximity therapeutics is in its ascendancy but is limited by a lack of scalable tools to systematically explore effector-target protein pairs in an unbiased manner. Here, we combined Scalable POoled Targeting with a LIgandable Tag at Endogenous Sites (SPOTLITES) for the high-throughput tagging of endogenous proteins, with generic small molecule-based protein recruitment to screen for novel proximity-based effectors. We apply this methodology in two orthogonal screens for targeted protein degradation: the first using fluorescence to monitor target protein levels directly, and the second using a cellular growth phenotype that depends on the degradation of an essential protein. Our screens revealed a multitude of potential new effector proteins for degradation and converged on members of the CTLH complex which we demonstrate potently induce degradation. Altogether, we introduce a platform for pooled induction of endogenous protein-protein interactions that can be used to expand our toolset of effector proteins for targeted protein degradation and other forms of induced proximity. American Journal Experts 2023-09-13 /pmc/articles/PMC10543026/ /pubmed/37790450 http://dx.doi.org/10.21203/rs.3.rs-3161717/v1 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.
spellingShingle Article
Serebrenik, Yevgeniy V.
Mani, Deepak
Maujean, Timothé
Burslem, George M.
Shalem, Ophir
Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics
title Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics
title_full Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics
title_fullStr Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics
title_full_unstemmed Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics
title_short Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics
title_sort pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543026/
https://www.ncbi.nlm.nih.gov/pubmed/37790450
http://dx.doi.org/10.21203/rs.3.rs-3161717/v1
work_keys_str_mv AT serebrenikyevgeniyv pooledendogenousproteintaggingandrecruitmentforscalablediscoveryofeffectorsforinducedproximitytherapeutics
AT manideepak pooledendogenousproteintaggingandrecruitmentforscalablediscoveryofeffectorsforinducedproximitytherapeutics
AT maujeantimothe pooledendogenousproteintaggingandrecruitmentforscalablediscoveryofeffectorsforinducedproximitytherapeutics
AT burslemgeorgem pooledendogenousproteintaggingandrecruitmentforscalablediscoveryofeffectorsforinducedproximitytherapeutics
AT shalemophir pooledendogenousproteintaggingandrecruitmentforscalablediscoveryofeffectorsforinducedproximitytherapeutics